MARATTO

article · Reviews in Medical Microbiology

COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic

Abstract

The world is standing up to new emergencies caused by viral infections. These viral strains have been verified to be the causative agents of pneumonia diseases. Coronavirus disease 2019 (COVID-19) viral infection was the world's most recent pandemic. After 2 years of examining its warnings, infection mechanisms, and the improvement of second and third-generation vaccines, these strategies were relatively significant against it. C OVID -19 gives rise to multiple variations in its genetic code to develop numerous exotic variants with the genetic code of the COVID-19 class. Omicron strain is a vastly recent and dangerous strain. It is the most rapidly spreading strain, bringing de novo mutagenesis mechanisms into the world in its spike proteins and receptor-binding domain. The well known mutations perceive that the vaccinations attained against COVID-19 will not be significant against Omicron. Our work reviews the mutagenesis mechanism of Omicron and its symptoms after the infection, immunogenicity against Omicron, and the booster dose utilized against it.

Research topics

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1097/mrm.0000000000000386

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.